Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in licensing deal making

 

2.1. Introduction

2.2. Definition of licensing deals

2.3. Success factors for licensing deals

2.4. When licensing can be useful

2.5. Attributes of licensing deals

2.6. Trends in licensing deals since 2012

2.6.1. Licensing deal making by year since 2012

2.6.2. Licensing deal making by phase of development since 2012

2.6.3. Licensing deal making by industry sector since 2012

2.6.4. Licensing deal making by therapy area since 2012

2.6.5. Licensing deal making by technology type since 2012

2.6.6. Licensing deal making by most active company since 2012

2.7. Option to license

2.8. Adding co-promotion to the mix

2.9. The future of licensing deals

 

Chapter 3 – Overview of licensing deal structure

 

3.1. Introduction

3.2. Pure versus multi-component licensing deals

3.3. Pure licensing agreement structure

3.3.1. Example licensing agreements

3.3.1.a. Case study 1: Ignyta – Nerviano Medical Sciences

3.3.1.b. Case study 2: Sanofi - Pozen

3.4. Licensing rights as part of a wider alliance agreement

3.4.1. Example licensing clauses

3.4.1.a. Case study 3: 4D Molecular Therapeutics – UniQure

3.4.1.b. Case study 4: Kyowa Hakko Kirin – Ultragenyx Pharmaceuticals

3.4.2. Example licensing option right clauses

3.4.2.a. Case study 5: Forest Laboratories - Trevena

3.4.2.b. Case study 6: Abbvie – Receptos

 

Chapter 4 – Leading licensing deals

 

4.1. Introduction

4.2. Top licensing deals by value

 

Chapter 5 – Top 50 most active licensing dealmakers

 

5.1. Introduction

5.2. Top 50 most active licensing dealmakers

 

Chapter 6 – Licensing deal term financials

 

6.1. Introduction

6.2. Licensing partnering headline values

6.3. Licensing deal upfront payments

6.4. Licensing deal milestone payments

6.5. Licensing royalty rates

 

Chapter 7 – Licensing contract directory since 2012

 

7.1. Introduction

7.2. Licensing deals with contracts since 2012

 

Appendices

 

Appendix 1 – Licensing dealmaking by companies A-Z

Appendix 2 – Licensing dealmaking by industry sector

Appendix 3 – Licensing dealmaking by stage of development

Appendix 4 – Licensing dealmaking by therapy area

Appendix 5 – Licensing dealmaking by technology type

 

About Wildwood Ventures

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

TABLE OF FIGURES

 

Figure 1: Definition of licensing

Figure 2: Situations where licensing can prove useful

Figure 3: Key attributes of a licensing deal

Figure 4: Trends in licensing deal announcements since 2012

Figure 5: Licensing deals signed at each phase of development since 2012

Figure 6: Licensing deals by industry sector since 2012

Figure 7: Licensing deals by therapy area since 2012

Figure 8: Licensing deals by technology type since 2012

Figure 9: Top 50 most active licensing dealmakers sinnce 2012

Figure 10: Licensing agreements – what should a contract include?

Figure 11: Components of the licensing deal structure

Figure 12: Top licensing deals by value since 2012

Figure 13: Most active licensing dealmakers since 2012

Figure 14: Licensing deals with a headline value

Figure 15: Licensing deals with an upfront value

Figure 16: Licensing deals with a milestone value

Figure 17: Licensing deals with a royalty rate value